Skip to main content
. 2021 Nov 23;13(23):5879. doi: 10.3390/cancers13235879

Table 2.

Baseline characteristics of patients who underwent next-generation sequencing using specimens obtained through endobronchial ultrasound-guided transbronchial needle aspiration.

Characteristics All Cases Success Cases Failure Cases p Value
(n = 156) (n = 130) (n = 26)
Age, years 70 (31–91) 70 (31–87) 70 (51–91) 0.54
Sex, male 103 (66.0) 84 (64.6) 19 (73.1) 0.50
Smoking history 0.47
Current or past 116 (74.4) 95 (73.1) 21 (80.8)
Never 40 (25.6) 35 (26.9) 5 (19.2)
Tumor clinical stage 0.81
II 3 (1.9) 3 (2.3) 0 (0)
III 64 (41.0) 53 (40.8) 11 (42.3)
IV 77 (49.4) 65 (50.0) 12 (46.2)
Recurrence 12 (7.7) 9 (6.9) 3 (11.5) -
Size of lymph nodes 0.45
Short axis on CT, mm 14.5 (5.2–66.8) 14.6 (5.2–66.8) 14.1 (7.5–43.7)
Necrotic finding on CT 0.52
Positive 70 (44.9) 60 (46.2) 10 (38.5)
Negative 86 (55.1) 70 (53.8) 16 (61.5)
Location of lymph nodes 0.62
Upper paratracheal (2R, 2L, 3p) 11 (7.1) 9 (6.9) 2 (7.7)
Lower paratracheal (4R, 4L) 60 (38.5) 51 (39.2) 9 (34.6)
Subcarinal (7) 43 (27.6) 34 (26.2) 9 (34.6)
Hilar (10R, 10L) 2 (1.3) 1 (0.8) 1 (3.8)
Interlobar and lobar (11, 12) 19 (12.3) 16 (12.3) 3 (11.5)
Others (lung, pleura) 21 (13.5) 19 (14.6) 2 (7.7)
Pathological diagnosis 0.48
Adenocarcinoma 101 (64.7) 86 (66.2) 15 (57.7)
Squamous cell carcinoma 21 (13.5) 18 (13.8) 3 (11.5)
Other subtypes or not otherwise specified 34 (21.8) 26 (20.0) 8 (30.8)
SUVmax on PET-CT 0.15
≥2.5 127 (81.4) 109 (83.8) 18 (69.2)
<2.5 17 (10.9) 13 (10.0) 4 (15.4)
Not evaluated 12 (7.7) 8 (6.2) 4 (15.4)

Data are presented as number (%) or median (range). Calculated using Fisher’s exact test or Mann–Whitney U test. CT, computed tomography; SUVmax, maximum standardized uptake value; PET, positron emission tomography.